Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

SillaJen to acquire Jennerex

Nov. 29, 2013

Genmab reaches milestone in Janssen Biotech collaboration

Nov. 27, 2013

Lytix Biopharma enrolls first patient in study of LTX-315

Nov. 27, 2013

E39 is well tolerated in patients with endometrial and ovarian cancer

Nov. 27, 2013

F-star generates an Fcab antibody against HER2

Nov. 21, 2013

Innate Pharma initiates program to develop anti-MICA antibody

Nov. 21, 2013

European approval for Kadcyla

Nov. 20, 2013

Generex Biotechnology reaches prespecified point in phase II trial of breast cancer vaccine

Nov. 19, 2013

First patient treated in study of DNX-2401 and temozolomide for recurrent glioblastoma

Nov. 15, 2013

Roche and immatics biotechnologies sign cancer vaccine collaboration

Nov. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...